The store will not work correctly when cookies are disabled.
N-(4-methoxyphenyl)-5-phenyloxazole-2-carboxamide
ID: ALA4876794
PubChem CID: 16949611
Max Phase: Preclinical
Molecular Formula: C17H14N2O3
Molecular Weight: 294.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(NC(=O)c2ncc(-c3ccccc3)o2)cc1
Standard InChI: InChI=1S/C17H14N2O3/c1-21-14-9-7-13(8-10-14)19-16(20)17-18-11-15(22-17)12-5-3-2-4-6-12/h2-11H,1H3,(H,19,20)
Standard InChI Key: XTHKURHQEJEUCN-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
4.0551 -22.4161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7034 -23.1563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1683 -23.8290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9849 -23.7626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3344 -23.0178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8673 -22.3483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1489 -22.9523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6837 -23.5701 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4366 -23.2524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3671 -22.4381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5712 -22.2527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1362 -23.6747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1202 -24.4917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8518 -23.2800 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5513 -23.7023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5300 -24.5170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2288 -24.9393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9453 -24.5445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9588 -23.7232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2593 -23.3047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6428 -24.9670 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3579 -24.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 2 0
5 7 1 0
9 12 1 0
12 13 2 0
12 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
21 22 1 0
18 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.31 | Molecular Weight (Monoisotopic): 294.1004 | AlogP: 3.60 | #Rotatable Bonds: 4 |
Polar Surface Area: 64.36 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.21 | CX Basic pKa: ┄ | CX LogP: 2.79 | CX LogD: 2.79 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.80 | Np Likeness Score: -1.17 |
References
1. Zhang R, Mo H, Ma YY, Zhao DG, Zhang K, Zhang T, Chen X, Zheng X.. (2021) Synthesis and structure-activity relationships of 5-phenyloxazole-2-carboxylic acid derivatives as novel inhibitors of tubulin polymerization., 40 [PMID:33753264] [10.1016/j.bmcl.2021.127968] |